
Stargardt disease is a genetic eye condition that causes central vision loss. It is a rare eye disease with no cure that usually develops in children, teenagers, and adults. Other names for the condition include Stargardt macular degeneration, fundus flavimaculatus, and ABCA4 retinopathy, which refers to the genetic mutation of the disease.
Stargardt disease causes the central part of the retina, the macula, which is crucial for central vision. The area is responsible for central vision sharpness and most of the eye’s ability to see the colors.
People with Stargardt disease rarely lose all of their central vision or any of their peripheral vision. Therapy can help people to manage their symptoms and perform their daily activities.
Signs and symptoms of Stargardt disease include:
People with this disease may experience symptoms at different levels of severity. Eye care providers will be able to identify changes in the shapes and colors of parts of your eyes.
This disease results from changes in the ABCA4 gene, which affects how the body uses vitamin A. The ABCA4 gene generates a protein that facilitates the removal of surplus fatty substances generated during the body’s utilization of vitamin A for retinal cell formation.
However, in the case of Stargardt disease, the malfunction of the ABCA4 gene results in the inhibition of this protein production, consequently causing the accumulation of fatty materials on the retina.
No, The Stargardt disease is not contagious. It’s not something you can transmit to or contract from anyone. This genetic disease is transmitted from one generation to the next through heredity.
Stargardt disease is a rare eye condition. The Macular Society in the United Kingdom states that only 1 in 10,000 people have this disease.
It is also a genetic disease; someone must inherit it from their biological parents. Usually, for symptoms to manifest, both parents must transmit the defective ABCA4 gene. However, rare forms of the disease only need one parent to pass down the gene for signs and symptoms to happen.
Genetic tests are available to determine the genes that can cause Stargardt disease. These tests can yield information about an individual’s gene carriage status, although they can occasionally produce inconclusive results.
An eye care specialist will diagnose the disease by examining the fatty materials around the retina. They may also assess the extent of the vision loss through tests, including:
Stargardt disease has no cure to prevent the macula from degenerating, but it can be manageable. Clinical trials are underway to explore treatment options for this form of macular degeneration and various other variants. Scientists are investigating metformin, a medication traditionally prescribed for diabetes management, as a potential pharmaceutical intervention to decelerate the advancement of Stargardt disease. They hope that metformin will improve the health of specific cells, including retinal cells.
Other clinical trials are centered on gene replacement therapy, aiming to provide a corrected version of the ABCA4 gene to replace the flawed variant. However, ABCA4 is very large, so its size presents a problem.
Other research focuses on methods to guide embryonic stem cells into differentiating into retinal pigment epithelium, potentially offering a promising avenue for vision restoration.
There are several things to manage Stargardt disease. Some of the ways are:
Your eye care specialists recommend regular check-ups to monitor your eye health. It’s crucial to maintain these appointments. Nevertheless, if you experience any changes in your vision or encounter pain and discomfort, you must contact your healthcare provider promptly.